1 The potential vasodilator function of the peptide ghrelin, recently identi®ed as the endogenous ligand of the growth hormone secretagogue orphan receptor (GHS-R), was investigated in human endothelium-denuded internal mammary artery. The peptide endothelin-1 (ET-1) is a potent and long-lasting vasoconstrictor. Comparisons were made with established and putative endogenous vasodilators to determine if any could reverse ET-1-induced vasoconstriction in this vessel. 2 Ghrelin (0.1 ± 300 nM) potently dilated 10 nM ET-1-induced constrictions (pD 2 8.39+0.29; E MAX 63+5.6%; n=9/14, responders/total). 3 ANP (pD 2 7.75+0.14; E MAX 106+2.0; n=5/5) and CGRP (pD 2 8.08+0.17; E MAX 76+15% n=5/6) both produced complete reversal of the constrictor response to ET-1 (E MAX not signi®cantly dierent from 100%, P40.05 one-sample t-test). 4 The following caused partial reversal of the ET-1 response: Adrenomedullin (n=9/9) and two peptides derived from proadrenomedullin, PAMP-12 (n=6/7) and PAMP-20 (n=9/9) (pD 2 values 7.63+0.28, 7.97+0.23 and 8.51+0.29; E MAX 58+7.3, 54+10 and 51+7.8% respectively). Unexpectedly, amylin was only 2 fold less potent than CGRP, although there was less than 50% reversal of the ET-1 constriction (pD 2 7.86+0.30; E MAX 41+5.4%; n=7/9). CNP (n=6/6) also partially reversed constrictions to ET-1 (E MAX 53+6.3; pD 2 8.07+0.38). 5 BNP (n=4/5) and PGI 2 (n=6/8) were weak vasodilators, since concentration-response curves failed to reach a maximum within the range tested. PGE 2 caused a small dilatation in some vessels (E MAX 17+2.1%; pD 2 8.63+0.36; n=4/8). 6 We have demonstrated ghrelin to be an eective, endothelium-independent vasodilator of the long-lasting constrictor ET-1 in human arteries producing responses similar to those of adrenomedullin (P40.05, ANOVA).